195 related articles for article (PubMed ID: 24239480)
1. Risk assessment of neonatal excipient exposure: lessons from food safety and other areas.
Turner MA; Duncan JC; Shah U; Metsvaht T; Varendi H; Nellis G; Lutsar I; Yakkundi S; McElnay JC; Pandya H; Mulla H; Vaconsin P; Storme T; Rieutord A; Nunn AJ
Adv Drug Deliv Rev; 2014 Jun; 73():89-101. PubMed ID: 24239480
[TBL] [Abstract][Full Text] [Related]
2. Harmful excipients in medicines for neonates in Spain.
Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
[TBL] [Abstract][Full Text] [Related]
3. Why are Excipients Important to Neonates?
Turner MA; Shah U
Curr Pharm Des; 2015; 21(39):5680-7. PubMed ID: 26323411
[TBL] [Abstract][Full Text] [Related]
4. Hospitalised neonates in Estonia commonly receive potentially harmful excipients.
Lass J; Naelapää K; Shah U; Käär R; Varendi H; Turner MA; Lutsar I
BMC Pediatr; 2012 Aug; 12():136. PubMed ID: 22931304
[TBL] [Abstract][Full Text] [Related]
5. Possible effects of excipients used in the parenteral drugs administered in critically ill adults, children, and neonates.
Sridharan K; Hasan HM; Al Jufairi M; Al Daylami A; Al Ansari E; Qader AM; Pasha SAA
Expert Opin Drug Saf; 2020 Dec; 19(12):1625-1640. PubMed ID: 32767900
[TBL] [Abstract][Full Text] [Related]
6. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.
Shehab N; Lewis CL; Streetman DD; Donn SM
Pediatr Crit Care Med; 2009 Mar; 10(2):256-9. PubMed ID: 19188870
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical Excipient Exposure in a Neonatal Intensive Care Unit.
Nasrollahi S; Meera NK; Boregowda S
Indian Pediatr; 2020 Sep; 57(9):801-804. PubMed ID: 32999107
[TBL] [Abstract][Full Text] [Related]
9. An Overview of Pharmaceutical Excipients: Safe or Not Safe?
Abrantes CG; Duarte D; Reis CP
J Pharm Sci; 2016 Jul; 105(7):2019-26. PubMed ID: 27262205
[TBL] [Abstract][Full Text] [Related]
10. A new approach to the safety assessment of pharmaceutical excipients. The Safety Committee of the International Pharmaceutical Excipients Council.
Steinberg M; Borzelleca JF; Enters EK; Kinoshita FK; Loper A; Mitchell DB; Tamulinas CB; Weiner ML
Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):149-54. PubMed ID: 8933628
[TBL] [Abstract][Full Text] [Related]
11. The Cumulative Daily Tolerance Levels of Potentially Toxic Excipients Ethanol and Propylene Glycol Are Commonly Exceeded in Neonates and Infants.
Valeur KS; Hertel SA; Lundstrøm KE; Holst H
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):523-530. PubMed ID: 29281181
[TBL] [Abstract][Full Text] [Related]
12. Best practices for selection of excipients for paediatrics - Workshop reflection.
Salunke S; Clapham D; Agrawal A; Hughes K; Nunn T
Eur J Pharm Biopharm; 2021 Mar; 160():77-81. PubMed ID: 33400989
[TBL] [Abstract][Full Text] [Related]
13. Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered.
Valeur KS; Holst H; Allegaert K
Pharmaceut Med; 2018; 32(4):251-258. PubMed ID: 30174435
[TBL] [Abstract][Full Text] [Related]
14. Potentially harmful excipients in neonatal medicines: a pan-European observational study.
Nellis G; Metsvaht T; Varendi H; Toompere K; Lass J; Mesek I; Nunn AJ; Turner MA; Lutsar I;
Arch Dis Child; 2015 Jul; 100(7):694-9. PubMed ID: 25854872
[TBL] [Abstract][Full Text] [Related]
15. The STEP (Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version.
Salunke S; Brandys B; Giacoia G; Tuleu C
Int J Pharm; 2013 Nov; 457(1):310-22. PubMed ID: 24070789
[TBL] [Abstract][Full Text] [Related]
16. Excipient exposure in very low birth weight preterm neonates.
Akinmboni TO; Davis NL; Falck AJ; Bearer CF; Mooney SM
J Perinatol; 2018 Feb; 38(2):169-174. PubMed ID: 29095430
[TBL] [Abstract][Full Text] [Related]
17. Vendor qualification for pharmaceutical excipients--GMP requirements and approach.
Patel KT; Chotal NP
Pharmazie; 2010 Nov; 65(11):783-90. PubMed ID: 21155382
[TBL] [Abstract][Full Text] [Related]
18. Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines.
Kogermann K; Lass J; Nellis G; Metsvaht T; Lutsar I
Curr Pharm Des; 2017; 23(38):5779-5789. PubMed ID: 28950820
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical excipients with potential to cause adverse effects in paediatric nasal medicines.
Stjepanovic AN; Todorovic NB; Tesic TZ; Komazec ZS; Canji-Panic JM; Lalic-Popovic MN
Regul Toxicol Pharmacol; 2022 Aug; 133():105225. PubMed ID: 35817211
[TBL] [Abstract][Full Text] [Related]
20. Safety issues with ethanol as an excipient in drugs intended for pediatric use.
Zuccotti GV; Fabiano V
Expert Opin Drug Saf; 2011 Jul; 10(4):499-502. PubMed ID: 21417862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
